Table 2.
Effects of volatile anaesthetic preconditioning on signal transduction proteins in endothelium
| Endothelium | Inhibition of endothelial NF-kappa B activation | Human umbilical vein, endothelial cells | Desflurane [58] |
| Inhibition of TNF-alpha-stimulated expression of adhesion molecules ICAM-1, VCAM-1 and E-selectin | Human umbilical vein, endothelial cells | Desflurane [59] | |
| Prevention of TNF-alpha-induced adhesion molecule expression | Human umbilical vein, endothelial cells | Isoflurane [60] | |
| Inhibition of endothelial leucocyte adhesion | Human volunteers | Sevoflurane [61] | |
| Preservation of glycocalix from I-R-induced degradation by attenuation of lysosomal cathepsin B release | Guinea pig hearts in vitro | Sevoflurane [62] | |
| Endothelial protection against ischaemia mediated by PKCs and mKATP channels |
Bovine pulmonary arterial endothelial cells | Isoflurane [63] | |
| NOSs (endothelial NOS and inducible NOS) | NOSs knockout mice | Desflurane [64] |
NF, nuclear factor; TNF, tumour necrosis factor; ICAM-1, intercellular adhesion molecule-1; VCAM-1, vascular adhesion molecule-1; I-R, cardiac ischaemia–reperfusion; PKC, protein kinase C; mKATP channel, mitochondrial ATP-sensitive potassium channel; NOSs, nitric oxide synthases.